Changsha Hongsen Biological Technology liability Co., Ltd. is founded in 2001, which is a collection of scientific research, production, trade as one of the credibility of enterprises, We have strong technical force and plentiful achievements in scientific research, and our products are exported to Europe, America and Southeast Asia.

At present, we mainly sell the products including E-liquid, pharmaceutical intermediates etc. We are the only company that microcapsule nanotechnology and supercritical technology are applied to all products by the professional R & D team, so the product of E-liquid taste fuller, milder and lasting. There are not only more than 140 different flavors of E-liquid in normal series, we also developed the following two unique E-liquid series:

1)Health care function series: The plant extracts with health care function are fused into e-liquid so that the product have the health care function with fresh breath, antioxidant, anti-inflammatory antimicrobial, immune regulation and anti-cancer tumor suppressor etc.

2) Nicotine replacement series: The chemical structure analogues or functional analogues of nicotine are extracted from natural plants to replace nicotine. It is not addictive, non-irritant to the respiratory tract and completely safe to human body.

In medical and health care field, we are successful to synthetise series of pharmaceutical intermediates including the total alkali, Vinblastine sulfate, Vinorelbine tartrate and Vinflunine etc, this series of products are the semi synthetic anticancer drugs, the antitumor activity is very strong, and the side effect is low.

We will keep the technological innovation as the driving force as always based on the market demand, and continue innovation in technology to set up the quality and win the market depend on quality.

Looking forward to cooperating with you and creating a win-win situation.